Literature DB >> 110126

Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation.

J C Forfar, H C Miller, A D Toft.   

Abstract

Serum total thyroxine, triiodothyronine and thyrotropin response to thyrotropin-releasing hormone were measured in 75 consecutive patients presenting to a cardiology clinic with atrial fibrillation with no obvious cardiovascular cause. A lack of response of serum thyrotropin to thyrotropin-releasing hormone, indicative of thyrotoxicosis, was found in 10 patients (13 percent), not all whom had raised serum thyroid hormone levels. These 10 patients were predominantly male, had no clinical signs of thyrotoxicosis and a relative excess of nonpalpable autonomous thyroid nodules demonstrated with scintigraphy. Eight of the 10 patients had reversion to stable sinus rhythm after treatment with iodine-131 or carbimazole, either spontaneously or after direct current cardioversion. It would appear that clinically occult thyrotoxicosis can be identified consistently only with the thyrotropin-releasing hormone test and is the cause of "idiopathic" atrial fibrillation in a significant proportion of patients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 110126     DOI: 10.1016/0002-9149(79)90243-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

Review 1.  Thyroid disease and the heart.

Authors:  A D Toft; N A Boon
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

2.  Effects of subclinical hyperthyroidism on renal handling of water and electrolytes in patients with nodular goiter.

Authors:  J J Corrales; J M Tabernero; J M Miralles; M T Hernández
Journal:  Klin Wochenschr       Date:  1991-01-04

Review 3.  Thyrotoxic atrial fibrillation.

Authors:  Malvinder S Parmar
Journal:  MedGenMed       Date:  2005-01-04

4.  Atrial fibrillation and the pituitary-thyroid axis: a re-evaluation.

Authors:  J C Forfar
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

5.  Atrial tachyarrhythmias induced by the combined effects of β1/2-adrenergic autoantibodies and thyroid hormone in the rabbit.

Authors:  Hongliang Li; Benjamin J Scherlag; David C Kem; Alexandria Benbrook; Ling Zhang; Bing Huang; Madeleine W Cunningham; Ralph Lazzara; Xichun Yu
Journal:  J Cardiovasc Transl Res       Date:  2014-06-06       Impact factor: 4.132

6.  Treatment of atrial fibrillation in a district general hospital.

Authors:  G Y Lip; K N Tean; F G Dunn
Journal:  Br Heart J       Date:  1994-01

7.  Graves' disease and atrial fibrillation: the case for even higher doses of therapeutic iodine-131.

Authors:  G R Scott; J C Forfar; A D Toft
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

8.  Fatty acid metabolism and thyroid hormones.

Authors:  Naomi L Sayre; James D Lechleiter
Journal:  Curr Trends Endocinol       Date:  2012-01-01

Review 9.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

10.  Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis.

Authors:  Torsten K Roepke; Elizabeth C King; Andrea Reyna-Neyra; Monika Paroder; Kerry Purtell; Wade Koba; Eugene Fine; Daniel J Lerner; Nancy Carrasco; Geoffrey W Abbott
Journal:  Nat Med       Date:  2009-09-20       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.